Goldman Sachs’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.32M | Sell |
|
|||||
|
2025
Q1 | $7.09M | Buy |
|
|||||
|
2024
Q4 | $7.03M | Buy |
|
|||||
|
2024
Q3 | $5.23M | Sell |
|
|||||
|
2024
Q2 | $4.96M | Sell |
|
|||||
|
2024
Q1 | $8.36M | Buy |
|
|||||
|
2023
Q4 | $18.5M | Buy |
|
|||||
|
2023
Q3 | $21.7M | Sell |
|
|||||
|
2023
Q2 | $29.1M | Sell |
|
|||||
|
2023
Q1 | $40.1M | Buy |
|
|||||
|
2022
Q4 | $38.3M | Buy |
|
|||||
|
2022
Q3 | $10.7M | Buy |
|